Vaccine Valley
Vaccine Valley is a leading biopharmaceutical company dedicated to developing, manufacturing, and marketing high-quality veterinary vaccines. Established in 2006, it aims to meet the needs of the Middle East, Africa, and other countries with advanced veterinary vaccines, emphasizing scientific expertise, innovation, and international quality standards. The company is committed to disease prevention in livestock, leveraging scientific research, European manufacturing standards, and a culture of teamwork and empowerment. It also specializes in the development and manufacturing of vaccines and biological products for veterinary and human health, with a strong focus on quality, safety, and environmental management.
Industries
Nr. of Employees
large (251-1000)
Vaccine Valley
Products
Inactivated multivalent poultry vaccine (H5/H9/Newcastle combinations)
High‑antigen‑mass inactivated injectable vaccine formulations combining antigens for avian influenza strains and Newcastle disease for flock protection; intended for subcutaneous or intramuscular administration (0.5 ml).
Inactivated Newcastle disease vaccine (single antigen)
High‑concentration inactivated Newcastle disease vaccine formulated for injectable administration (0.5 ml) to protect poultry flocks against NDV.
Pentavalent inactivated poultry vaccine (multivalent)
Multivalent inactivated vaccine combining multiple avian influenza antigens and Newcastle disease components for broad respiratory pathogen coverage; injectable 0.5 ml dose.
Vaccine development pipeline (live, recombinant, nucleic acid candidates)
R&D pipeline including live attenuated vaccines, recombinant antigen formulations and nucleic acid vaccine candidates intended for future veterinary use.
Inactivated multivalent poultry vaccine (H5/H9/Newcastle combinations)
High‑antigen‑mass inactivated injectable vaccine formulations combining antigens for avian influenza strains and Newcastle disease for flock protection; intended for subcutaneous or intramuscular administration (0.5 ml).
Inactivated Newcastle disease vaccine (single antigen)
High‑concentration inactivated Newcastle disease vaccine formulated for injectable administration (0.5 ml) to protect poultry flocks against NDV.
Pentavalent inactivated poultry vaccine (multivalent)
Multivalent inactivated vaccine combining multiple avian influenza antigens and Newcastle disease components for broad respiratory pathogen coverage; injectable 0.5 ml dose.
Vaccine development pipeline (live, recombinant, nucleic acid candidates)
R&D pipeline including live attenuated vaccines, recombinant antigen formulations and nucleic acid vaccine candidates intended for future veterinary use.
Services
On‑farm vaccination delivery and application quality control
End‑to‑end on‑farm vaccination service including vaccine preparation, dose monitoring, application (injectable), equipment maintenance and vaccinator training with emphasis on biosafety and correct administration.
Farm sampling and field surveillance
Regular on‑farm sample collection and monitoring to evaluate vaccination success and flock health; samples are processed using HA/HI, ELISA, PCR and sequencing and forwarded to accredited diagnostic laboratories.
Contract R&D, technical support and industry outreach
Research and development services including vaccine formulation, challenge study design, scientific consultancy, and organization of conferences and awareness campaigns to educate producers on disease control.
Autogenous (custom) vaccine development
Development of custom vaccines generated from viral or bacterial isolates collected from affected flocks to produce strain‑specific protection for a single farm or production system.
Facility engineering and cleanroom project delivery
Design and implementation of GMP facilities including cleanrooms, HVAC, utilities and automation projects to support biomanufacturing operations.
Regulatory documentation and registration support
Consulting and documentation services to assist CTD preparation, dossier management and multi‑country product registration activities.
On‑farm vaccination delivery and application quality control
End‑to‑end on‑farm vaccination service including vaccine preparation, dose monitoring, application (injectable), equipment maintenance and vaccinator training with emphasis on biosafety and correct administration.
Farm sampling and field surveillance
Regular on‑farm sample collection and monitoring to evaluate vaccination success and flock health; samples are processed using HA/HI, ELISA, PCR and sequencing and forwarded to accredited diagnostic laboratories.
Contract R&D, technical support and industry outreach
Research and development services including vaccine formulation, challenge study design, scientific consultancy, and organization of conferences and awareness campaigns to educate producers on disease control.
Autogenous (custom) vaccine development
Development of custom vaccines generated from viral or bacterial isolates collected from affected flocks to produce strain‑specific protection for a single farm or production system.
Facility engineering and cleanroom project delivery
Design and implementation of GMP facilities including cleanrooms, HVAC, utilities and automation projects to support biomanufacturing operations.
Regulatory documentation and registration support
Consulting and documentation services to assist CTD preparation, dossier management and multi‑country product registration activities.
Expertise Areas
- Veterinary vaccine development
- Inactivated and live attenuated vaccine production
- Vaccine formulation and adjuvantation
- Autogenous (custom) vaccine development
Key Technologies
- SPF egg‑based antigen production
- Inactivated vaccine manufacturing
- Live attenuated vaccine production
- Recombinant antigen production